Guidance for use of neurofilament light chain as a cerebrospinal fluid and blood biomarker in multiple sclerosis management

Summary: Neurofilament light chain (NfL) is a long-awaited blood biomarker that can provide clinically useful information about prognosis and therapeutic efficacy in multiple sclerosis (MS). There is now substantial evidence for this biomarker to be used alongside magnetic resonance imaging (MRI) an...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Mark S. Freedman, Sharmilee Gnanapavan, Ronald A. Booth, Peter A. Calabresi, Michael Khalil, Jens Kuhle, Jan Lycke, Tomas Olsson
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Elsevier 2024-03-01
coleção:	EBioMedicine
Assuntos:	Multiple sclerosis Neurofilament light chain Cerebrospinal fluid biomarkers Serum biomarkers
Acesso em linha:	http://www.sciencedirect.com/science/article/pii/S2352396424000057
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!